(MENAFN- NewsIn.Asia)
Oct 12 (CNN) – The policy-making body of the World Health Organization has recommended that a third dose of the Sinovac and Sinopharm COVID-19 vaccines should be offered to persons aged 60 and above and those whose immune systems are diminished.
The WHO Strategic Advisory Group of Experts (WHO SAGE) said all evidence reviewed showed a need for a third dose of the same vaccine for those who have completed the two doses of inactivated vaccines produced by Chinese manufacturers Sinovac and Sinopharm.
For similar articles, join our Whatsapp group for the latest updates. – click here
SAGE chairperson Alejandro Cravioto, however, said a different brand can be considered as the third dose if there is enough supply.
“This should be started to be offered to people aged 60 and above since they are the ones that have shown the biggest problem in response,” he said in a briefing on Monday.
SAGE published highlights from its meeting conducted from Oct. 4 to 7, saying nations should initially aim to fully vaccinate senior citizens before administering the third dose by starting in the oldest age groups.
READ: Fully vaccinated & had Covid-19? No rush for a booster shot
Subscribe to our Whatsapp channel for the latest updates from around the world
Covid-19 Sinopharm Sinovac Vaccine WHO
MENAFN12102021000191011043ID1102960276
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.